INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)
Clinical trial NCT04398433 · COMPLETED
Trial details
- NCT number
- NCT04398433
- Sponsor
- Inovio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-07
- Primary completion
- 2022-12-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.